ADDvise Group’s total order intake during the first quarter 2020 amounted to MSEK 137.3 corresponding to an increase of 63 per cent compared with the same period last year. The order intake for the same period last year amounted to MSEK 84.4. 37 per cent of the increase in order intake is due to organic growth. In addition, it is a significant increase compared to the preliminary order intake that was published through the press release dated 24 March 2020. The strong order intake is partly due to the intensified use of medical equipment and consumables due to the outbreak of COVID-19.
The result of the first quarter will be negatively affected, materially. This is due to interruptions in the supply chain and ADDvise Group personnel, because of absence due to illness.
- The order intake during the first quarter is an all-time high. Unfortunately, during this present market conditions we do not have the ability to turn the order intake into revenue to the extent desired, said Rikard Akhtarzand, CEO, commenting the order intake.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Important information:
This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 6 April 2020 at 09:50 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.